![Hugo Vanderstichele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hugo Vanderstichele
Geen lopende functies
Profiel
Hugo Vanderstichele is the founder and has worked as a Director of Assay Development at ADx NeuroSciences NV, which he founded in 2011.
He received his undergraduate degree from Ghent University.
Eerdere bekende functies van Hugo Vanderstichele
Bedrijven | Functie | Einde |
---|---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Oprichter | - |
Opleiding van Hugo Vanderstichele
Ghent University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
ADx NeuroSciences NV
![]() ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |